Shingles vaccine study for adults 40 and older
Part of Infections clinical trials.
This trial tests a live shingles vaccine to see how well it works and how safe it is. It may help prevent shingles in adults aged 40 and up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 40 or older
- No weakened immune system (e.g., from cancer, HIV/AIDS, or treatments like chemotherapy)
- No history of severe allergic reaction to any vaccine component
- Not pregnant, breastfeeding, or planning pregnancy within 6 months
- No prior shingles or chickenpox vaccination
- No uncontrolled high blood pressure (systolic ≥160 or diastolic ≥100)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This study tests an experimental shingles vaccine in adults aged 40 and older. It aims to see if the vaccine is safe and helps your body build immunity against shingles.
This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.
This study tests a new shingles vaccine to make sure each batch works the same way. If you are 40 or older and have never had shingles or the shingles vaccine, you may qualify.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
This study tests a live-attenuated shingles vaccine as a booster for people who have already had a recombinant shingles vaccine. It aims to see if the booster is safe and helps maintain protection against shingles.
Hear when a new Prevention of Herpes Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.